The Pharmacy Times® Skin Cancer Resource Center is a comprehensive resource for clinical news and expert insights on cancers that occur on the skin, including basal cell carcinoma, squamous cell carcinoma, and melanoma.
January 22nd 2025
Vusolimogene oderparepvec in combination with nivolumab is being assessed to treat individuals with unresectable or metastatic stage IIIb-IV cutaneous melanoma.